Home LiteratureArticle Details
PMID: 6767959 Published · ppublish ger Clinical Trial English Abstract Journal Article Randomized Controlled Trial

[The single daily dose of gentamicin in the treatment of urinary tract infections (author's transl)].

Die tägliche Einmaldosis von Gentamicin bei der Behandlung von Harnwegsinfektionen.

MMW, Munchener medizinische Wochenschrift ·Vol. 122 ·No. 6 ·1980-02-08 ·Pages 212-4

Angelov A, Barrientos G, Gutensohn G, Lenzner A

Abstract

Gentamicin was administered intravenously or intramuscularly to 165 patients with non-obstructive urinary tract infections. 3 prospectively randomised groups were formed in which gentamicin was given either once daily (120 mg), twice daily (40/80 mg) or three times daily (40 mg). Clinically and bacteriologically an equally good improvement of the condition appeared in all groups. The mode of application selected had no influence on the therapeutic success in 86--95%. Since with the single daily injection of 120 mg gentamicin the proportion of side effects did not increase, this therapeutic plan can be recommended for outpatient treatment in urological and internal medical practice.

MeSH Terms
Adult Aged Drug Administration Schedule Female Gentamicins/administration & dosage,therapeutic use Humans Injections, Intramuscular Injections, Intravenous Male Middle Aged Urinary Tract Infections/drug therapy
Chemicals
Gentamicins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Angelov A
Barrientos G
Gutensohn G
Lenzner A
Article Info
Journal
MMW, Munchener medizinische Wochenschrift
Abbr.
MMW Munch Med Wochenschr
ISSN
0341-3098
Published
1980-02-08
Pages
212-4
Language
ger
Region
Germany
NLM ID
7801805
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]